Vestal Point Capital’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,429
Closed -$9.05M 60
2023
Q4
$9.05M Buy
+11,429
New +$9.05M 0.96% 26